{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:02:31Z","timestamp":1790773351815,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012304","name":"Johns Hopkins School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ajo.2026.07.033","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:50:58Z","timestamp":1785455458000},"page":"341-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Stem Cell Therapy for Inherited Retinal Disorders: Rebuilding the Retina"],"prefix":"10.1016","volume":"291","author":[{"given":"ANUPAM K.","family":"GARG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ISHRAT","family":"AHMED","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajo.2026.07.033_bib0001","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ajmg.c.31534","article-title":"Gene and cell-based therapies for inherited retinal disorders: an update","volume":"172","author":"Sengillo","year":"2016","journal-title":"Am J Med Genet Pt C"},{"key":"10.1016\/j.ajo.2026.07.033_bib0002","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ajo.2025.07.021","article-title":"Trends and disparities in the incidence and prevalence of inherited retinal diseases in the United States","volume":"279","author":"Abbass","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.07.033_bib0003","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/ceo.13917","article-title":"Inherited retinal diseases: therapeutics, clinical trials and end points\u2014a review","volume":"49","author":"Georgiou","year":"2021","journal-title":"Clin Exper Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2026.07.033_bib0004","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1167\/iovs.64.7.39","article-title":"Gene therapy for retinal degenerative diseases: progress, challenges, and future directions","volume":"64","author":"Drag","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10097","key":"10.1016\/j.ajo.2026.07.033_bib0005","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2026.07.033_bib0006","doi-asserted-by":"crossref","DOI":"10.21037\/sci-2020-001","article-title":"Current state of stem cell-based therapies: an overview","volume":"7","author":"Aly","year":"2020","journal-title":"Stem Cell Investig"},{"key":"10.1016\/j.ajo.2026.07.033_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.01.004","article-title":"Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases","volume":"58","author":"Jones","year":"2017","journal-title":"Progr Retin Eye Res"},{"issue":"7396","key":"10.1016\/j.ajo.2026.07.033_bib0008","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature10997","article-title":"Restoration of vision after transplantation of photoreceptors","volume":"485","author":"Pearson","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0009","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.stem.2008.10.015","article-title":"Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in CRX-deficient mice","volume":"4","author":"Lamba","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.ajo.2026.07.033_bib0010","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1073\/pnas.1119416110","article-title":"Reversal of end-stage retinal degeneration and restoration of visual function by photoreceptor transplantation","volume":"110","author":"Singh","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0011","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1073\/pnas.1212677110","article-title":"Repair of the degenerate retina by photoreceptor transplantation","volume":"110","author":"Barber","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.ajo.2026.07.033_bib0012","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1074\/jbc.M113.513713","article-title":"Human retinal progenitor cell transplantation preserves vision","volume":"289","author":"Luo","year":"2014","journal-title":"J Biolog Chem"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/srep29784","article-title":"Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice","volume":"6","author":"Barnea-Cramer","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0014","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1512590113","article-title":"Transplantation of human embryonic stem cell-derived retinal tissue in two primate models of retinal degeneration","volume":"113","author":"Shirai","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.ajo.2026.07.033_bib0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.10.10.13","article-title":"One-year follow-up in a phase 1\/2a clinical trial of an allogeneic RPE cell bioengineered implant for advanced dry age-related macular degeneration","volume":"10","author":"Kashani","year":"2021","journal-title":"Trans Vis Sci Tech"},{"issue":"48","key":"10.1016\/j.ajo.2026.07.033_bib0016","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1523\/JNEUROSCI.3719-06.2006","article-title":"Transplantation of Human neural stem cells exerts neuroprotection in a rat model of Parkinson\u2019s disease","volume":"26","author":"Yasuhara","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajo.2026.07.033_bib0017","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.expneurol.2014.11.014","article-title":"Neural progenitor cell transplantation promotes neuroprotection, enhances hippocampal neurogenesis, and improves cognitive outcomes after traumatic brain injury","volume":"264","author":"Blaya","year":"2015","journal-title":"Experiment Neurol"},{"issue":"2","key":"10.1016\/j.ajo.2026.07.033_bib0018","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cne.20176","article-title":"Human neural stem cell transplants improve motor function in a rat model of Huntington\u2019s disease","volume":"475","author":"McBride","year":"2004","journal-title":"J Compar Neurol"},{"issue":"3","key":"10.1016\/j.ajo.2026.07.033_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000338","article-title":"Protection of visual functions by human neural progenitors in a rat model of retinal disease","volume":"2","author":"Gamm","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2026.07.033_bib0020","first-page":"472","article-title":"Gene expression changes in the retina following subretinal injection of human neural progenitor cells into a rodent model for retinal degeneration","volume":"22","author":"Jones","year":"2016","journal-title":"Mol Vis"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0021","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1186\/s12967-023-04501-z","article-title":"GMP-grade human neural progenitors delivered subretinally protect vision in rat model of retinal degeneration and survive in minipigs","volume":"21","author":"Lu","year":"2023","journal-title":"J Transl Med"},{"issue":"15","key":"10.1016\/j.ajo.2026.07.033_bib0022","doi-asserted-by":"crossref","first-page":"8060","DOI":"10.3390\/ijms25158060","article-title":"Amelioration of photoreceptor degeneration by intravitreal transplantation of retinal progenitor cells in rats","volume":"25","author":"Yang","year":"2024","journal-title":"IJMS"},{"key":"10.1016\/j.ajo.2026.07.033_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1646156","article-title":"Retinal progenitor cells (jCell) for retinitis pigmentosa","volume":"19","author":"Yang","year":"2025","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.ajo.2026.07.033_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101317","article-title":"Cellular component transfer between photoreceptor cells of the retina","volume":"104","author":"Wang","year":"2025","journal-title":"Progr Retin Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13028","article-title":"Retinal transplantation of photoreceptors results in donor\u2013host cytoplasmic exchange","volume":"7","author":"Santos-Ferreira","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0026","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13537","article-title":"Transplanted photoreceptor precursors transfer proteins to host photoreceptors by a mechanism of cytoplasmic fusion","volume":"7","author":"Singh","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0027","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13287-019-1165-5","article-title":"Stem cells: past, present, and future","volume":"10","author":"Zakrzewski","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.ajo.2026.07.033_bib0028","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.aanat.2016.11.010","article-title":"Overview of retinal differentiation potential of mesenchymal stem cells: a promising approach for retinal cell therapy","volume":"210","author":"Salehi","year":"2017","journal-title":"Ann Anat"},{"issue":"3","key":"10.1016\/j.ajo.2026.07.033_bib0029","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/1574888X16666210804112104","article-title":"Stem cell-based treatment strategies for degenerative diseases of the retina","volume":"17","author":"Nair","year":"2022","journal-title":"CSCR"},{"issue":"6","key":"10.1016\/j.ajo.2026.07.033_bib0030","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/life14060668","article-title":"Exploring stem-cell-based therapies for retinal regeneration","volume":"14","author":"Radu","year":"2024","journal-title":"Life"},{"issue":"4","key":"10.1016\/j.ajo.2026.07.033_bib0031","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ajo.2026.07.033_bib0032","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous induced stem-cell\u2013derived retinal cells for macular degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ajo.2026.07.033_bib0033","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/dgd.12072","article-title":"Comparing brain-derived neurotrophic factor and ciliary neurotrophic factor secretion of induced neurotrophic factor secreting cells from human adipose and bone marrow-derived stem cells","volume":"55","author":"Razavi","year":"2013","journal-title":"Dev Growth Differ"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0034","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13287-023-03526-x","article-title":"Stem cell therapy for inherited retinal diseases: a systematic review and meta-analysis","volume":"14","author":"Chen","year":"2023","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13287-020-02122-7","article-title":"Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa","volume":"12","author":"Tuekprakhon","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"10.1016\/j.ajo.2026.07.033_bib0036","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.ophtha.2018.04.037","article-title":"Transplantation of human embryonic stem cell-derived retinal pigment epithelial cells in macular degeneration","volume":"125","author":"Mehat","year":"2018","journal-title":"Ophthalmology"},{"issue":"9967","key":"10.1016\/j.ajo.2026.07.033_bib0037","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt\u2019s macular dystrophy: follow-up of two open-label phase 1\/2 studies","volume":"385","author":"Schwartz","year":"2015","journal-title":"Lancet"},{"issue":"27","key":"10.1016\/j.ajo.2026.07.033_bib0038","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1606","article-title":"Suprachoroidal gene transfer with nonviral nanoparticles","volume":"6","author":"Shen","year":"2020","journal-title":"Sci Adv"},{"issue":"30","key":"10.1016\/j.ajo.2026.07.033_bib0039","doi-asserted-by":"crossref","first-page":"46913","DOI":"10.18632\/oncotarget.10442","article-title":"Cell surgery and growth factors in dry age-related macular degeneration: visual prognosis and morphological study","volume":"7","author":"Limoli","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0040","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13287-023-03489-z","article-title":"Suprachoroidal spheroidal mesenchymal stem cell implantation in retinitis pigmentosa: clinical results of 6 months follow-up","volume":"14","author":"\u00d6zkan","year":"2023","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"10.1016\/j.ajo.2026.07.033_bib0041","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.stem.2023.11.004","article-title":"Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosa","volume":"30","author":"Hirami","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.ajo.2026.07.033_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100770","article-title":"Transplant of induced pluripotent stem cell\u2013derived retinal pigment epithelium strips for macular degeneration and retinitis pigmentosa","volume":"5","author":"Sakai","year":"2025","journal-title":"Ophthalmol Sci"},{"issue":"2","key":"10.1016\/j.ajo.2026.07.033_bib0043","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/IAE.0000000000003655","article-title":"Transplantation of subretinal stem cell-derived retinal pigment epithelium for Stargardt disease: a phase I clinical trial","volume":"43","author":"Brant Fernandes","year":"2023","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.ajo.2026.07.033_bib0044","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.stemcr.2015.04.005","article-title":"Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients","volume":"4","author":"Song","year":"2015","journal-title":"Stem Cell Rep"},{"issue":"6","key":"10.1016\/j.ajo.2026.07.033_bib0045","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bjophthalmol-2020-316225","article-title":"Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients","volume":"105","author":"Sung","year":"2021","journal-title":"Brit J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2026.07.033_bib0046","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13100","article-title":"A phase I clinical trial of human embryonic stem cell-derived retinal pigment epithelial cells for early-stage Stargardt macular degeneration: 5-years\u2019 follow-up","volume":"54","author":"Li","year":"2021","journal-title":"Cell Proliferat"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0047","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13287-016-0432-y","article-title":"Subretinal adipose tissue-derived mesenchymal stem cell implantation in advanced stage retinitis pigmentosa: a phase I clinical safety study","volume":"7","author":"Oner","year":"2016","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0048","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13287-020-1549-6","article-title":"Management of retinitis pigmentosa by Wharton\u2019s jelly derived mesenchymal stem cells: preliminary clinical results","volume":"11","author":"\u00d6zmert","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"10.1016\/j.ajo.2026.07.033_bib0049","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/stcltm\/szad051","article-title":"Management of retinitis pigmentosa via Wharton\u2019s jelly-derived mesenchymal stem cells or combination with magnovision: 3-year prospective results","volume":"12","author":"Ozmert","year":"2023","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"10.1016\/j.ajo.2026.07.033_bib0050","first-page":"564","article-title":"Subtenon implantation of Wharton\u2019s jelly-derived mesenchymal stromal cells in retinitis pigmentosa","volume":"77","author":"Nor Khairullah","year":"2022","journal-title":"Med J Malaysia"},{"issue":"6","key":"10.1016\/j.ajo.2026.07.033_bib0051","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/cell.2018.0045","article-title":"Suprachoroidal adipose tissue-derived mesenchymal stem cell implantation in patients with dry-type age-related macular degeneration and Stargardt\u2019s macular dystrophy: 6-month follow-up results of a phase 2 study","volume":"20","author":"Oner","year":"2018","journal-title":"Cell Reprogr"},{"issue":"9","key":"10.1016\/j.ajo.2026.07.033_bib0052","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.18240\/ijo.2020.09.14","article-title":"Umbilical cord derived mesenchymal stem cell implantation in retinitis pigmentosa: a 6-month follow-up results of a phase 3 trial","volume":"13","author":"Kahraman","year":"2020","journal-title":"Int J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2026.07.033_bib0053","doi-asserted-by":"crossref","DOI":"10.1093\/stcltm\/szaf034","article-title":"Evaluating the long-term efficacy of umbilical cord-derived mesenchymal stem cell therapy in retinitis pigmentosa: findings from a 1-to-4-year follow-up","volume":"14","author":"Oner","year":"2025","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"10.1016\/j.ajo.2026.07.033_bib0054","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/IAE.0b013e3181f9c242","article-title":"Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial","volume":"31","author":"Siqueira","year":"2011","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1167\/iovs.14-15415","article-title":"Intravitreal autologous bone marrow CD34\u00fe cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings","volume":"56","author":"Park","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100589","article-title":"Phase I study of intravitreal injection of autologous CD34+ stem cells from bone marrow in eyes with vision loss from retinitis pigmentosa","volume":"5","author":"Park","year":"2025","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.ajo.2026.07.033_bib0057","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8828256","article-title":"Intravitreal use of a bone marrow mononuclear fraction (BMMF) containing CD34+ cells in patients with Stargardt type macular dystrophy","volume":"2020","author":"Cotrim","year":"2020","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.ajo.2026.07.033_bib0058","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21037\/sci.2019.11.01","article-title":"Stem cell ophthalmology treatment study (SCOTS): bone marrow derived stem cells in the treatment of dominant optic atrophy","volume":"6","author":"Weiss","year":"2019","journal-title":"Stem Cell Investig"},{"issue":"5","key":"10.1016\/j.ajo.2026.07.033_bib0059","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/ICB.0000000000001032","article-title":"Bilateral epiretinal membrane formation after intravitreal injection of autologous mesenchymal stem cells","volume":"16","author":"Kasetty","year":"2022","journal-title":"Retin Cases Brief Rep"},{"issue":"3","key":"10.1016\/j.ajo.2026.07.033_bib0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/ICB.0000000000000327","article-title":"Epiretinal membrane formation after intravitreal autologous stem cell implantation in a retinitis pigmentosa patient","volume":"11","author":"Kim","year":"2017","journal-title":"Retin Cases Brief Rep"},{"issue":"16","key":"10.1016\/j.ajo.2026.07.033_bib0061","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1089\/scd.2020.0037","article-title":"Intravenous infusion of umbilical cord mesenchymal stem cells maintains and partially improves visual function in patients with advanced retinitis pigmentosa","volume":"29","author":"Zhao","year":"2020","journal-title":"Stem Cells Developm"},{"issue":"1","key":"10.1016\/j.ajo.2026.07.033_bib0062","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13287-017-0661-8","article-title":"Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients","volume":"8","author":"Liu","year":"2017","journal-title":"Stem Cell Res Ther"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426004204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426004204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:52:55Z","timestamp":1790772775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426004204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":62,"alternative-id":["S0002939426004204"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.07.033","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem Cell Therapy for Inherited Retinal Disorders: Rebuilding the Retina","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}